Identification of SP1683 as a pneumococcal protein that is protective against nasopharyngeal colonization

References

• World Health Organization. Pneumococcal vaccines WHO position paper. 2012. http://www.who.int/wer/2012/wer8714.pdf?ua = 1.
   Google Scholar
• Smart LE, Dougall AJ, Girdwood RWA. New 23-valent pneumococcal vaccine in relation to pneumococcal serotypes in systemic and non-systemic disease. J Infect. 1987;14:209–15. doi:10.1016/S0163-4453(87)93360-3.
   PubMed Web of Science ®Google Scholar
• Advisory Committee on Immunization Practices. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1997;46:1–24.
   Google Scholar
• van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet. 2009;374:1543–56. doi:10.1016/S0140-6736(09)61114-4.
   PubMed Web of Science ®Google Scholar
• Koskela M, Leinonen M, Häivä VM, Timonen M, Mäkelä PH. First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants. Pediatr Infect Dis. 1986;5:45–50. doi:10.1097/00006454-198601000-00009.
   PubMedGoogle Scholar
• Bogaert D, Hermans PWM, Adrian PV, Rümke HC, de Groot R. Pneumococcal vaccines: an update on current strategies. Vaccine. 2004;22:2209–20. doi:10.1016/j.vaccine.2003.11.038.
   PubMed Web of Science ®Google Scholar
• Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, Elvin L, Ensor KM, Hackell J, Siber G, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000;19:187–95.
   PubMed Web of Science ®Google Scholar
• Prymula R, Peeters P, Chrobok V, Kriz P, Novakova E, Kaliskova E, Kohl I, Lommel P, Poolman J, Prieels J-P, et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet. 2006;367:740–8. doi:10.1016/S0140-6736(06)68304-9.
   PubMed Web of Science ®Google Scholar
• Deceuninck G, De Serres G, Boulianne N, Lefebvre B, De Wals P. Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada. Vaccine. 2015;33:2684–9. doi:10.1016/j.vaccine.2015.04.005.
   PubMed Web of Science ®Google Scholar
• Lu CY, Huang LM. Is Pneumococcal Serotype Replacement Impending? Pediatr Neonatol. 2016;57:363–4. doi:10.1016/j.pedneo.2015.08.012.
   PubMed Web of Science ®Google Scholar
• Bittaye M, Cash P. Streptococcus pneumoniae proteomics: determinants of pathogenesis and vaccine development. Expert Rev Proteomics. 2015;12:607–21. doi:10.1586/14789450.2015.1108844.
   PubMed Web of Science ®Google Scholar
• Barocchi MA, Censini S, Rappuoli R. Vaccines in the era of genomics: the pneumococcal challenge. Vaccine. 2007;25:2963–73. doi:10.1016/j.vaccine.2007.01.065.
   PubMed Web of Science ®Google Scholar
• Feldman C, Anderson R. Review: Current and new generation pneumococcal vaccines. J Infect. 2014;69:309–25. doi:10.1016/j.jinf.2014.06.006.
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Khan MN, Xu Q. Next generation protein based Streptococcus pneumoniae vaccines. Hum Vaccin Immunother. 2016;12:194–205. doi:10.1080/21645515.2015.1052198.
   PubMed Web of Science ®Google Scholar
• Rajam G, Anderton JM, Carlone GM, Sampson JS, Ades EW. Pneumococcal surface adhesin A (PsaA): a review. Crit Rev Microbiol. 2008;34:163–73. doi:10.1080/10408410802383610.
   PubMed Web of Science ®Google Scholar
• Giefing C, Meinke AL, Hanner M, Henics T, Minh DB, Gelbmann D, Lundberg U, Senn BM, Schunn M, Habel A, et al. Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies. J Exp Med. 2008;205:117–31. doi:10.1084/jem.20071168.
   PubMed Web of Science ®Google Scholar
• Shah P, Swiatlo E. Immunization with polyamine transport protein PotD protects mice against systemic infection with Streptococcus pneumoniae. Infect Immun. 2006;74:5888–92. doi:10.1128/IAI.00553-06.
   PubMed Web of Science ®Google Scholar
• Shah P, Briles DE, King J, Hale Y, Swiatlo E. Mucosal immunization with polyamine transport protein D (PotD) protects mice against nasopharyngeal colonization with Streptococcus pneumoniae. Exp Biol Med (Maywood). 2009;234:403–9. doi:10.3181/0809-RM-269.
   PubMed Web of Science ®Google Scholar
• Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis. 1999;20:3551–67. doi:10.1002/(SICI)1522-2683(19991201)20:18%3c3551::AID-ELPS3551%3e3.0.CO;2-2.
   PubMed Web of Science ®Google Scholar
• Adamou JE, Heinrichs JH, Erwin AL, Walsh W, Gayle T, Dormitzer M, Dagan R, Brewah YA, Barren P, Lathigra R, et al. Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis. Infect Immun. 2001;69:949–58. doi:10.1128/IAI.69.2.949-958.2001.
   PubMed Web of Science ®Google Scholar
• Denoël P, Philipp MT, Doyle L, Martin D, Carletti G, Poolman JT. A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae. Vaccine. 2011;29:5495–501. doi:10.1016/j.vaccine.2011.05.051.
   PubMed Web of Science ®Google Scholar
• Godfroid F, Hermand P, Verlant V, Denoël P, Poolman JT. Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens. Infect Immun. 2011;79:238–45. doi:10.1128/IAI.00378-10.
   PubMed Web of Science ®Google Scholar
• Moffitt KL, Gierahn TM, Lu YJ, Gouveia P, Alderson M, Flechtner JB, Higgins DE, Malley R. TH17-based vaccine design for prevention of Streptococcus pneumoniae colonization. Cell Host Microbe. 2011;9:158–65. doi:10.1016/j.chom.2011.01.007.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Clarke TB, Weiser JN. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest. 2009;119:1899–909.
   PubMed Web of Science ®Google Scholar
• Marion C, Burnaugh AM, Woodiga SA, King SJ. Sialic acid transport contributes to pneumococcal colonization. Infect Immun. 2011;79:1262–9. doi:10.1128/IAI.00832-10.
   PubMed Web of Science ®Google Scholar
• Leroux-Roels I, Devaster JM, Leroux-Roels G, Verlant V, Henckaerts I, Moris P, Hermand P, Van Belle P, Poolman JT, Vandepapeliere P, et al. Adjuvant system AS02v enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: randomised, controlled trials. Vaccine. 2015;33:577–84. doi:10.1016/j.vaccine.2013.10.052.
   PubMed Web of Science ®Google Scholar
• Leroux-Roels G, Maes C, De Boever F, Traskine M, Rüggeberg JU, Borys D. Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: a phase I/II randomized clinical study. Vaccine. 2014;32:6838–46. doi:10.1016/j.vaccine.2014.02.052.
   PubMed Web of Science ®Google Scholar
• Prymula R, Pazdiora P, Traskine M, Rüggeberg JU, Borys D. Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: a phase II randomized clinical trial. Vaccine. 2014;32:3025–34. doi:10.1016/j.vaccine.2014.03.066.
   PubMed Web of Science ®Google Scholar
• Bogaert D, de Groot R, Hermans PWM. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004;4:144–54. doi:10.1016/S1473-3099(04)00938-7.
   PubMed Web of Science ®Google Scholar
• Malley R, Trzcinski K, Srivastava A, Thompson CM, Anderson PW, Lipsitch M. CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc Natl Acad Sci U S A. 2005;102:4848–53. doi:10.1073/pnas.0501254102.
   PubMed Web of Science ®Google Scholar
• Moffitt KL, Malley R, Lu YJ. Identification of protective pneumococcal TH17 antigens from the soluble fraction of a killed whole cell vaccine. PLoS One. 2012;7:e43445. doi:10.1371/journal.pone.0043445.
   PubMed Web of Science ®Google Scholar
• Lu YJ, Gross J, Bogaert D, Finn A, Bagrade L, Zhang Q, Kolls JK, Srivastava A, Lundgren A, Forte S, et al. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog. 2008;4:e1000159. doi:10.1371/journal.ppat.1000159.
   PubMed Web of Science ®Google Scholar
• Khan MN, Pichichero ME. The host immune dynamics of pneumococcal colonization: implications for novel vaccine development. Hum Vaccin Immunother. 2014;10:3688–99. doi:10.4161/21645515.2014.979631.
   PubMed Web of Science ®Google Scholar
• Tournoy KG, Depraetere S, Meuleman P, Leroux-Roels G, Pauwels RA. Murine IL-2 receptor beta chain blockade improves human leukocyte engraftment in SCID mice. Eur J Immunol. 1998;28:3221–30. doi:10.1002/(SICI)1521-4141(199810)28:10%3c3221::AID-IMMU3221%3e3.0.CO;2-S.
   PubMed Web of Science ®Google Scholar
• Encheva V, Gharbia SE, Wait R, Begum S, Shah HN. Comparison of extraction procedures for proteome analysis of Streptococcus pneumoniae and a basic reference map. Proteomics. 2006;6:3306–17. doi:10.1002/pmic.200500744.
   PubMed Web of Science ®Google Scholar
• Rioux S, Neyt C, Di Paolo E, Turpin L, Charland N, Labbé S, Mortier M-C, Mitchell TJ, Feron C, Martin D, et al. Transcriptional regulation, occurrence and putative role of the Pht family of Streptococcus pneumoniae. Microbiology. 2011;157:335–48. doi:10.1099/mic.0.042184-0.
   Web of Science ®Google Scholar
• Hermand P, Vandercammen A, Mertens E, Di Paolo E, Verlant V, Denoël P, Godfroid F. Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen. Hum Vaccin Immunother. 2017;13:220–8 doi:10.1080/21645515.2016.1234553.
   PubMed Web of Science ®Google Scholar
• Moens L, Wuyts M, Meyts I, De Boeck K, Bossuyt X. Human memory B lymphocyte subsets fulfill distinct roles in the anti-polysaccharide and anti-protein immune response. J Immunol. 2008;181:5306–12. doi:10.4049/jimmunol.181.8.5306.
   PubMed Web of Science ®Google Scholar
• Romero-Steiner S, Libutti D, Pais LB, Dykes J, Anderson P, Whitin JC, Keyserling HL, Carlone GM. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin Diagn Lab Immunol. 1997;4:415–22.
   PubMedGoogle Scholar
• Zhang Y, Masi AW, Barniak V, Mountzouros K, Hostetter MK, Green BA. Recombinant PhpA protein, a unique histidine motif-containing protein from Streptococcus pneumoniae, protects mice against intranasal pneumococcal challenge. Infect Immun. 2001;69:3827–36. doi:10.1128/IAI.69.6.3827-3836.2001.
   PubMed Web of Science ®Google Scholar
• Briles DE, Hollingshead SK, Paton JC, Ades EW, Novak L, van Ginkel FW, Benjamin WH, Jr. Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae. J Infect Dis. 2003;188:339–48. doi:10.1086/376571.
   PubMed Web of Science ®Google Scholar
• Holmlund E, Quiambao B, Ollgren J, Nohynek H, Käyhty H. Development of natural antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A and pneumolysin in Filipino pregnant women and their infants in relation to pneumococcal carriage. Vaccine. 2006;24:57–65. doi:10.1016/j.vaccine.2005.07.055.
   PubMed Web of Science ®Google Scholar
• Baril L, Briles DE, Crozier P, King J, Punar M, Hollingshead SK, McCormick JB. Characterization of antibodies to PspA and PsaA in adults over 50 years of age with invasive pneumococcal disease. Vaccine. 2004;23:789–93. doi:10.1016/j.vaccine.2004.07.033.
   PubMed Web of Science ®Google Scholar
• McCool TL, Cate TR, Moy G, Weiser JN. The immune response to pneumococcal proteins during experimental human carriage. J Exp Med. 2002;195:359–65. doi:10.1084/jem.20011576.
   PubMed Web of Science ®Google Scholar
• Bologa M, Kamtchoua T, Hopfer R, Sheng X, Hicks B, Bixler G, Hou V, Pehlic V, Yuan T, Gurunathan S. Safety and immunogenicity of pneumococcal protein vaccine candidates: monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein D vaccine. Vaccine. 2012;30:7461–8. doi:10.1016/j.vaccine.2012.10.076.
   PubMed Web of Science ®Google Scholar
• Brooks WA, Chang LJ, Sheng X, Hopfer R. Safety and immunogenicity of a trivalent recombinant PcpA, PhtD, and PlyD1 pneumococcal protein vaccine in adults, toddlers, and infants: A phase I randomized controlled study. Vaccine. 2015;33:4610–7. doi:10.1016/j.vaccine.2015.06.078.
   PubMed Web of Science ®Google Scholar
• Briles DE, Hollingshead SK, King J, Swift A, Braun PA, Park MK, Ferguson LM, Nahm MH, Nabors GS. Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA. J Infect Dis. 2000;182:1694–701. doi:10.1086/317602.
   PubMed Web of Science ®Google Scholar
• Linder A, Hollingshead S, Janulczyk R, Christensson B, Akesson P. Human antibody response towards the pneumococcal surface proteins PspA and PspC during invasive pneumococcal infection. Vaccine. 2007;25:341–5. doi:10.1016/j.vaccine.2006.07.028.
   PubMed Web of Science ®Google Scholar
• Seo JY, Seong SY, Ahn BY, Kwon IC, Chung H, Jeong SY. Cross-protective immunity of mice induced by oral immunization with pneumococcal surface adhesin a encapsulated in microspheres. Infect Immun. 2002;70:1143–9. doi:10.1128/IAI.70.3.1143-1149.2002.
   PubMed Web of Science ®Google Scholar
• Ling E, Feldman G, Portnoi M, Dagan R, Overweg K, Mulholland F, Chalifa-Caspi V, Wells J, Mizrachi-Nebenzahl Y. Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse. Clin Exp Immunol. 2004;138:290–8. doi:10.1111/j.1365-2249.2004.02628.x.
   PubMed Web of Science ®Google Scholar
• Laine C, Mwangi T, Thompson CM, Obiero J, Lipsitch M, Scott JAG. Age-specific immunoglobulin g (IgG) and IgA to pneumococcal protein antigens in a population in coastal kenya. Infect Immun. 2004;72:3331–5. doi:10.1128/IAI.72.6.3331-3335.2004.
   PubMed Web of Science ®Google Scholar
• Simell B, Kilpi T, Käyhty H. Subclass distribution of natural salivary IgA antibodies against pneumococcal capsular polysaccharide of type 14 and pneumococcal surface adhesin A (PsaA) in children. Clin Exp Immunol. 2006;143:543–9. doi:10.1111/j.1365-2249.2006.03009.x.
   PubMed Web of Science ®Google Scholar
• Scott JA, Obiero J, Hall AJ, Marsh K. Validation of immunoglobulin G enzyme-linked immunosorbent assay for antibodies to pneumococcal surface adhesin A in the diagnosis of pneumococcal pneumonia among adults in Kenya. J Infect Dis. 2002;186:220–6. doi:10.1086/341205.
   PubMed Web of Science ®Google Scholar
• Beghetto E, Gargano N, Ricci S, Garufi G, Peppoloni S, Montagnani F, Oggioni M, Pozzi G, Felici F. Discovery of novel Streptococcus pneumoniae antigens by screening a whole-genome λ-display library. FEMS Microbiol Lett. 2006;262:14–21. doi:10.1111/j.1574-6968.2006.00360.x.
   PubMed Web of Science ®Google Scholar
• Wizemann TM, Heinrichs JH, Adamou JE, Erwin AL, Kunsch C, Choi GH, Barash SC, Rosen CA, Masure HR, Tuomanen E, et al. Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect Immun. 2001;69:1593–8. doi:10.1128/IAI.69.3.1593-1598.2001.
   PubMed Web of Science ®Google Scholar
• Zysk G, Bongaerts RJM, ten Thoren E, Bethe G, Hakenbeck R, Heinz HP. Detection of 23 immunogenic pneumococcal proteins using convalescent-phase serum. Infect Immun. 2000;68:3740–3. doi:10.1128/IAI.68.6.3740-3743.2000.
   PubMed Web of Science ®Google Scholar
• Bethe G, Nau R, Wellmer A, Hakenbeck R, Reinert RR, Heinz HP, Zysk G. The cell wall-associated serine protease PrtA: a highly conserved virulence factor of Streptococcus pneumoniae. FEMS Microbiol Lett. 2001;205:99–104. doi:10.1111/j.1574-6968.2001.tb10931.x.
   PubMed Web of Science ®Google Scholar
• Whiting GC, Evans JT, Patel S, Gillespie SH. Purification of native alpha-enolase from Streptococcus pneumoniae that binds plasminogen and is immunogenic. J Med Microbiol. 2002;51:837–43. doi:10.1099/0022-1317-51-10-837.
   PubMed Web of Science ®Google Scholar
• Hamel J, Martin D, Brodeur BB. Heat shock response of Streptococcus pneumoniae: identification of immunoreactive stress proteins. Microb Pathog. 1997;23:11–21. doi:10.1006/mpat.1996.0124.
   PubMed Web of Science ®Google Scholar
• Kolberg J, Hòiby EA, Aase A, Sletten K, Rodal G, Michaelsen TE, Bucher A. Streptococcus pneumoniae heat shock protein 70 does not induce human antibody responses during infection. FEMS Immunol Med Microbiol. 2000;29:289–94. doi:10.1111/j.1574-695X.2000.tb01536.x.
   PubMedGoogle Scholar
• Cao J, Chen D, Xu W, Chen T, Xu S, Luo J, Zhao Q, Liu B, Wang D, Zhang X, et al. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP. Vaccine. 2007;25:4996–5005. doi:10.1016/j.vaccine.2007.04.069.
   PubMed Web of Science ®Google Scholar
• Kwon HY, Ogunniyi AD, Choi MH, Pyo SN, Rhee DK, Paton JC. The ClpP protease of Streptococcus pneumoniae modulates virulence gene expression and protects against fatal pneumococcal challenge. Infect Immun. 2004;72:5646–53. doi:10.1128/IAI.72.10.5646-5653.2004.
   PubMed Web of Science ®Google Scholar